Drug Profile
BCD 800
Alternative Names: BCD-800Latest Information Update: 28 Jan 2021
Price :
$50
*
At a glance
- Originator BIOCND; Undisclosed
- Developer Pharma Research BIO; Undisclosed Company
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Liver cirrhosis
Most Recent Events
- 28 Jan 2021 No recent reports of development identified for research development in Liver-Cirrhosis in South Korea
- 16 Dec 2016 Early research in Cirrhosis in South Korea (unspecified route)